The Congo ebola outbreak has recorded one of its deadliest weeks yet, with 317 deaths reported in seven days. The sharp rise has raised fresh concerns over the spread of the virus in eastern Congo. The latest figures bring the reported outbreak...
Recent developments from Johnson & Johnson, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Pulnovo Medical and Bayer highlight how pharmaceutical innovation, generic manufacturing and advanced medical technology strengthen critical care
Recent milestones from Roche, Eli Lilly, GSK, REGENXBIO and Sonova demonstrate how innovation is expanding beyond conventional medicines into blood-based diagnostics
India’s new Medical Device Rule could increase compliance costs for manufacturers. The rule requires makers to disclose details of outsourced sterilization facilities on device labels. The medical device rule is aimed at improving traceability...
A H1N1 Alert has prompted a key health review meeting in Delhi. Health Minister Dr Pankaj Kumar Singh will lead the meeting at the Delhi Secretariat this afternoon. The H1N1 Alert comes as officials review hospital preparedness and testing measures
The latest drug recall by Sun Pharmaceutical Industries has drawn attention to a manufacturing quality issue involving its epilepsy medicine carbamazepine
Goa’s new cancer rule could change how cancer cases are tracked across the state. The Goa government has declared cancer a notifiable disease, making case reporting mandatory. The move is aimed at improving the collection of cancer data.
Today's pharma news includes drug launches, USFDA approvals, and obesity drugs as global pharmaceutical companies push new treatments and expand manufacturing capacity
Calcium Gluconate has become the latest addition to Glenmark Pharmaceuticals' U.S. injectable portfolio, this move supports its strategy to build a differentiated, sustainable U.S. injectables business focused on institutional demand
Mankind Pharma has signed an in-licensing deal with China’s Chongqing Chenan Biopharmaceutical to commercialise two insulin analogues in India and strengthen its diabetes portfolio.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")